Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.13.5483

Clinical and Prognostic Significance of SOX11 in Breast Cancer  

Liu, Dao-Tong (Department of General Surgery, The First People's Hospital of Jining City Affiliated to Jining Medical University)
Peng-Zhao, Peng-Zhao (Department of Cardiothoracic Surgery, Jinxiang Hospital Affiliated to Jining Medical University)
Han, Jing-Yan (Department of Cardiothoracic Surgery, People's Hospital of Rizhao City)
Lin, Fan-Zhong (Department of Pathology, The First People's Hospital of Jining City Affiliated to Jining Medical University)
Bu, Xian-Min (Department of Pathology, The First People's Hospital of Jining City Affiliated to Jining Medical University)
Xu, Qing-Xia (Department of Pathology, The First People's Hospital of Jining City Affiliated to Jining Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.13, 2014 , pp. 5483-5486 More about this Journal
Abstract
Recently, the transcription factor SOX11 has gained extensive attention as a diagnostic marker in a series of cancers. However, to date, the possible roles of SOX11 in breast cancer has not been investigated. In this study, immunohistochemical staining for SOX11 was performed for 116 cases of breast cancer. Nuclear SOX11 was observed in 42 (36.2%) and cytoplasmic SOX11 in 52 (44.8%) of breast cancer samples. Moreover, high expression of cytoplasmic and nuclear SOX11 was associated with clinicopathological factors, including earlier tumor grade, absence of lymph node metastasis and smaller tumor size. Kaplan-Meier survival curves demonstrated high nuclear SOX11 expression to be associated with more prolonged overall survival than those with low expression and it could be an independent predictor of survival for breast cancer patients. It is worthwhile to note that cytoplasmic SOX11 was not correlated with prognosis of breast cancer patients. These data suggest the possibility that nuclear SOX11 could be as a potential target for breast cancer therapy.
Keywords
SOX11; breast cancer; nuclear location; survival; prognosis;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Pardali K, Moustakas A (2007). Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta, 1775, 21-62.
2 Mutlu H, Akca Z, Cihan YB, et al (2013). Is season a prognostic factor in breast cancer? Asian Pac J Cancer Prev, 14, 743-6.   과학기술학회마을   DOI   ScienceOn
3 Siegel PM, Massague J (2003). Cytostatic and apoptotic actions of TGF- beta in homeostasis and cancer. Nat Rev Cancer, 3, 807-21.   DOI   ScienceOn
4 Wang X, Asplund AC, Porwit A, et al (2008). The subcellular SOX11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol, 143, 248-52.   DOI   ScienceOn
5 Wegner M (1999). From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res, 27, 1409-20.   DOI   ScienceOn
6 Weigle B, Ebner R, Temme A, et al (2005). Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol Rep, 13, 139-44.
7 Zhang S, Li S, Gao JL (2013). Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma. Cancer Cell Int, 13, 109.   DOI   ScienceOn
8 Hargrave M, Wright E, Kun J, et al (1997). Expression of the SOX11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction. Dev Dyn, 210, 79-86.   DOI
9 Conrotto P, Andreasson U, Kuci V, Borrebaeck CA, Ek S (2011). Knock- down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo. Mol Oncol, 5, 527-37.   DOI   ScienceOn
10 Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA (2008). Nuclear expression of the non B-cell lineage SOX11 transcription factor identifies mantle cell lymphoma. Blood, 111, 800-5.   DOI   ScienceOn
11 Fernandez V, Salamero O, Espinet B, et al (2010). Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer research, 70, 1408-18.   DOI
12 Khan HM, Saxena A, Gabbidon K, Rana S, Ahmed NU (2014). Model-based survival estimates of female breast cancer data. Asian Pac J Cancer Prev, 15, 2893-900.   과학기술학회마을   DOI   ScienceOn
13 Kiefer JC (2007). Back to basics: SOX genes. Dev Dyn, 236, 2356-66.   DOI   ScienceOn
14 Lee CJ, Appleby VJ, Orme AT, et al (2002). Differential expression of Sox4 and SOX11 in medulloblastoma. J. NeuroOncol, 57, 201-14.   DOI   ScienceOn
15 Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B (2007). Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol, 39, 2195-214.   DOI   ScienceOn
16 Mozos A, Royo C, Hartmann E, et al (2009). SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica, 94, 1555-62.   DOI   ScienceOn
17 Azuma T, Ao S, Saito Y, et al (1999). Human SOX11, an upregulated gene during the neural differentiation, has a long 3' untranslated region. DNA Res, 6, 357-60.   DOI
18 Bergsland M, Werme M, Malewicz M, et al (2006). The establishment of neuronal properties is controlled by Sox4 and SOX11. Genes Dev, 20, 3475-86.   DOI   ScienceOn
19 Brennan DJ, Ek S, Doyle E, et al (2009). The transcription factor SOX11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer, 45, 1510-7.   DOI   ScienceOn
20 Chen YH, Gao J, Fan G, Peterson LC (2010). Nuclear expression of SOX11 is highly associated with mantle cell lymphoma but is independent of t (11;14)(q13; q32) in non-mantle cell B-cell neoplasms. Mod Pathol, 23, 105-12.   DOI   ScienceOn
21 Madjd Z, Akbari ME, Zarnani AH, et al (2014). Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas. Asian Pac J Cancer Prev, 15: 1783-9.   과학기술학회마을   DOI   ScienceOn
22 Press MF, Pike MC, Chazin VR, et al (1993). Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression within creased risk of recurrent disease. Cancer Res, 53, 4960-70.